Pharmaceutical News

RSS

VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.

30 Oct 2009

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Responding to delays in the nationwide distribution H1N1 flu vaccine, Department of Health officials today urged Pennsylvanians to continue to take steps to prevent the spread of illness.

30 Oct 2009

Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards

INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.

30 Oct 2009

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

With just 36 hours notice from the Maricopa County Department of Public Health, Mollen Immunization Clinics administered over 14,000 vaccinations to high-risk groups throughout the county, one of the nation's largest with a population of four million residents.

30 Oct 2009

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.

30 Oct 2009

36 individuals in Kentucky face federal prescription pill charges

The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.

30 Oct 2009

Mintel predicts increased sales of OTC drugs in upcoming months

Autumn has arrived in the northern hemisphere and with shades of yellow and orange comes a less-welcome visitor: cold and flu season. Made worse this year by the H1N1 (swine flu) pandemic, people around the world are flocking to drugstores and supermarkets to stock up on over-the-counter (OTC) medicine, says market research firm Mintel.

30 Oct 2009

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

ExonHit Therapeutics yesterday presented clinical data on the validation set “Alzheimer patients versus healthy controls” for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer’s disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer’s Disease (CTAD) in Las Vegas, USA.

30 Oct 2009

ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone

ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has implemented a staffing plan to operate the company that anticipates licensing its lead development programs and resuming development of earlier stage product candidates.

30 Oct 2009

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

30 Oct 2009

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

30 Oct 2009

USANA’s Active Calcium Chewable supplement improves bone health in young girls

USANA Health Sciences, Inc. announced today that a third-party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA’s Active Calcium™ Chewable supplement improves bone health in young girls.

30 Oct 2009

Any cuts to the prescription drug program will affect senior citizens, says Network/Alliance

The Older Canadians Network / Alliance of Seniors (Network/Alliance) is warning the Ontario government that any cuts to the prescription drug program would disproportionately affect the province's senior citizens.

30 Oct 2009

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Total Nutraceutical Solutions, Inc., announced today that it has received approval for importation of ImmuSANO™ and GlucoSANO™ from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles.

30 Oct 2009

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.

30 Oct 2009

Virtual Pharma Rep 360 Managed Care solution released

Virtual Pharma Rep™, a new company built by pharmaceutical industry veterans, today announced the release of Virtual Pharma Rep 360 Managed Care. This module builds on the existing Virtual Pharma Rep virtual sales platform of patent pending technology designed to significantly decrease the marketing, sales and educational expenses in the pharmaceutical sales and education process.

30 Oct 2009

Comparative study of chronic wound treatment completed

The comparative study of chronic wound treatment at the Hospital Civil of Cd. Victoria, Tamaulipas, Mexico, was concluded successfully. Due to the significantly superior therapeutic success the Ministry of Health ordered the control to be abandoned and moved to Hemospray treatment for ethical reasons.

30 Oct 2009

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.

30 Oct 2009

All Canadians need to be immunized against H1N1: CPHA

The Canadian Public Health Association (CPHA) announced today that it is encouraging Canadians to get the H1N1 vaccination. To help people make an informed choice, it is launching a new online portal of information.

30 Oct 2009

Researchers use BEZ235 drug to eliminate NSCL cancer

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

30 Oct 2009

Pharmaceutical News

VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Trusted Process thought leaders at INC Research named winners at the 2009 Clinical Research Excellence Awards

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

36 individuals in Kentucky face federal prescription pill charges

Mintel predicts increased sales of OTC drugs in upcoming months

Clinical data on the validation set 'Alzheimer patients versus healthy controls' for AclarusDx presented

ARYx Therapeutics to complete an out-licensing agreement for clinical development and commercialization of budiodarone

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

USANA’s Active Calcium Chewable supplement improves bone health in young girls

Any cuts to the prescription drug program will affect senior citizens, says Network/Alliance

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Virtual Pharma Rep 360 Managed Care solution released

Comparative study of chronic wound treatment completed

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

All Canadians need to be immunized against H1N1: CPHA

Researchers use BEZ235 drug to eliminate NSCL cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News